Treating COVID-19 patients with EMDR: A pilot study

Brennstuhl, Marie-Jo; Tarquinio, Pascale; Rydberg, Jenny Ann; Tarquinio, Camille; Peter, Lydia; Christine, Rotonda; Tarquinio, Cyril

doi:10.1016/j.ejtd.2022.100276

Cited by 5 publications

(16 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…(Supplementary Table 4G). (Brennstuhl et al, 2022 ; Dinapoli et al, 2023 ; Mooren et al, 2022 ) (Bates et al, 2022 ; Brennstuhl et al, 2022 ; Mooren et al, 2022 ) (Bates et al, 2022 ; Brennstuhl et al, 2022 ; Mooren et al, 2022 ) (Bates et al, 2022 ; Yurtsever et al, 2022 ) (Brennstuhl et al, 2022 ) (Dinapoli et al, 2023 ) (Mooren et al, 2022 ) (Bates et al, 2022 ; Mooren et al, 2022 ) (Bates et al, 2022 ) (Bates et al, 2022 ) (Mooren et al, 2022 ) (Bates et al, 2022 ) (Bates et al, 2022 ; Brennstuhl et al, 2022 ; Yurtsever et al, 2022 ) (Bates et al, 2022 )…”

Section: Resultsmentioning

confidence: 99%

Eye Movement Desensitization and Reprocessing (EMDR) treatment in the medical setting: a systematic review

Driessen,

Morsink,

Busschbach

et al. 2024

European Journal of Psychotraumatology

View full text Add to dashboard Cite

Background: Literature points towards the potential benefits of the application of Eye Movement and Desensitization Processing (EMDR)-therapy for patients in the medical setting, with cancer and pain being among the domains it is applied to. The field of applying EMDR-therapy for patients treated in the medical setting has evolved to such an extent that it may be challenging to get a comprehensive overview. Objective: This systematic literature review aims to evaluate the use and effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy in patients treated in the medical setting. Methods: We performed a literature search following the PRISMA guidelines. Studies were included if the effectiveness of EMDR-therapy was assessed in adult patients treated in a medical setting. Excluded were patients exclusively suffering from a mental health disorder, without somatic comorbidity. A risk of bias analysis was performed. This review was registered on PROSPERO (CRD42022325238). Results: Eighty-seven studies, of which 26 (pilot)-RCTs were included and categorized in 14 medical domains. Additionally, three studies focusing on persistent physical complaints were included. Most evidence exists for its application in the fields of oncology, pain, and neurology. The overall appraisal of these studies showed at least moderate to high risks of bias. EMDR demonstrated effectiveness in reducing symptoms in 85 out of 87 studies. Notably, the occurrence of adverse events was rarely mentioned. Conclusions: Overall, outcomes seem to show beneficial effects of EMDR on reducing psychological and physical symptoms in patients treated in a medical setting. Due to the heterogeneity of reported outcomes, effect sizes could not be pooled. Due to the high risk of bias of the included studies, our results should be interpreted with caution and further controlled high-quality research is needed.

show abstract

Section: Resultsmentioning

confidence: 99%

Eye Movement Desensitization and Reprocessing (EMDR) treatment in the medical setting: a systematic review

Driessen,

Morsink,

Busschbach

et al. 2024

European Journal of Psychotraumatology

View full text Add to dashboard Cite

show abstract

“…Most of the studies had been conducted in China ( n = 15) ( 30 , 33 , 34 , 45 , 50 , 52–55 , 63 , 64 , 66–69 ), Iran ( n = 6) ( 38 , 47 , 48 , 58 , 61 , 62 ), Italy ( n = 5) ( 29 , 31 , 41 , 44 , 57 ), India ( n = 4) ( 36 , 46 , 56 , 59 ), United States ( n = 2) ( 28 , 35 ), and Korea ( n = 2) ( 49 , 65 ). The remaining studies had been developed in Saudi Arabia ( n = 1) ( 27 ), Nigeria ( n = 1) ( 32 ), Indonesia ( n = 1) ( 39 ), France ( n = 1) ( 42 ), Turkey ( n = 1) ( 43 ), Thailand ( n = 1) ( 51 ), Latvia ( n = 1) ( 40 ), Ghana ( n = 1) ( 37 ), and Poland ( n = 1) ( 60 ).…”

Section: Resultsmentioning

confidence: 99%

“…With regard to study design, the most common study design was randomized controlled trials ( n = 15) ( 43 , 45 , 47 , 50 , 52–56 , 58 , 60–62 , 64 , 69 ) followed by case studies ( n = 14) ( 27–40 ). Other study designs included pre-post studies without control group ( n = 9) ( 41 , 42 , 44 , 49 , 57 , 59 , 63 , 65 , 67 ) and non-randomized studies with control group ( n = 5) ( 46 , 48 , 51 , 66 , 68 ).…”

Section: Resultsmentioning

confidence: 99%

Guiding future research on psychological interventions in people with COVID-19 and post COVID syndrome and comorbid emotional disorders based on a systematic review

Martínez-Borba,

Martínez-García,

Peris-Baquero

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

ObjectiveThe COVID-19 pandemic has been emotionally challenging for the entire population and especially for people who contracted the illness. This systematic review summarizes psychological interventions implemented in COVID-19 and long COVID-19 patients who presented comorbid emotional disorders.Methods and measures3,839 articles were identified in 6 databases and 43 of them were included in this work. Two independent researchers selected the articles and assessed their quality.Results2,359 adults were included in this review. Severity of COVID-19 symptoms ranged from asymptomatic to hospitalized patients; only 3 studies included long COVID-19 populations. Similar number of randomized controlled studies (n = 15) and case studies (n = 14) were found. Emotional disorders were anxiety and/or depressive symptoms (n = 39) and the psychological intervention most represented had a cognitive behavioral approach (n = 10). Length of psychological programs ranged from 1–5 sessions (n = 6) to 16 appointments (n = 2). Some programs were distributed on a daily (n = 4) or weekly basis (n = 2), but other proposed several sessions a week (n = 4). Short (5–10 min, n = 4) and long sessions (60–90 min, n = 3) are proposed. Most interventions were supported by the use of technologies (n = 18). Important risk of bias was present in several studies.ConclusionPromising results in the reduction of depressive, anxiety and related disorders have been found. However, important limitations in current psychological interventions were detected (i.e., duration, format, length, and efficacy of interventions were not consistently established across investigations). The results derived from our work may help to understand clinical practices in the context of pandemics and could guide future efforts to manage emotional suffering in COVID-19 patients. A stepped model of care could help to determine the dosage, length and format of delivery for each patient.Systematic review registration: PROSPERO 2022 CRD42022367227. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022367227

show abstract

“…Five studies focused on the efficacy of EMDR in pulmonary disorders: four studies focused on COVID-19 and one study on COPD (Supplementary Table 4G). The efficacy of EMDR was evaluated on symptoms of distress, [83][84][85] anxiety, 83,84,86 depression, 83,84,86 PTSD, 86,87 fear, 83 dissociative disorders, 85 dyspnea, fatigue, emotional function and mastery, 84 QoL, 84,86 resilience 86 and appetite and predicted weight. 86 Additionally, one study conducted interviews 84 and one study evaluated the feasibility of delivering online therapy.…”

Section: Pulmonary Medicinementioning

confidence: 99%

“…86 All studies found significant beneficial effects of EMDR when comparing measurements before and directly after treatment, although not on every outcome measure, and these effects remained at follow-up. 83,86,87 One RCT study compared EMDR+TAU to TAU and found significant improvements in the EMDR+TAU group but did not find a significant difference between groups. 86 Cardiology Four studies described the use of EMDR in cardiac events and all studies were (pilot-)RCTs: see Supplementary Table 4H.…”

Section: Pulmonary Medicinementioning

confidence: 99%

Eye Movement Desensitization and Reprocessing (EMDR) Treatment in the Medical Setting: A Systematic Review

Driessen,

Morsink,

Busschbach

et al. 2023

Preprint

View full text Add to dashboard Cite

Treating COVID-19 patients with EMDR: A pilot study

Cited by 5 publications

References 43 publications

Eye Movement Desensitization and Reprocessing (EMDR) treatment in the medical setting: a systematic review

Eye Movement Desensitization and Reprocessing (EMDR) treatment in the medical setting: a systematic review

Guiding future research on psychological interventions in people with COVID-19 and post COVID syndrome and comorbid emotional disorders based on a systematic review

Eye Movement Desensitization and Reprocessing (EMDR) Treatment in the Medical Setting: A Systematic Review

Contact Info

Product

Resources

About